Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

Alexander Zimprich, Saskia Biskup, Petra Leitner, Peter Lichtner, Matthew Farrer, Sarah Lincoln, Jennifer Kachergus, Mary Hulihan, Ryan J. Uitti, Donald B. Calne, A. Jon Stoessl, Ronald Pfeiffer, Nadja Patenge, Iria Carballo Carbajal, Peter Vieregge, Friedrich Asmus, Bertram Müller-Myhsok, Dennis W. Dickson, Thomas Meitinger, Tim M. StromZbigniew K. Wszolek, Thomas Gasser

Research output: Contribution to journalArticle

1842 Citations (Scopus)

Abstract

We have previously linked families with autosomal-dominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathology, and progressive supranuclear palsy-like pathology. Clinical diagnoses of Parkinsonism with dementia or amyotrophy or both, with their associated pathologies, are also noted. Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism.

Original languageEnglish (US)
Pages (from-to)601-607
Number of pages7
JournalNeuron
Volume44
Issue number4
DOIs
StatePublished - Nov 18 2004
Externally publishedYes

Fingerprint

Parkinsonian Disorders
Leucine
Phosphotransferases
Pathology
Mutation
MAP Kinase Kinase Kinases
Progressive Supranuclear Palsy
Lewy Body Disease
Chromosome Mapping
Substantia Nigra
Missense Mutation
Neurodegenerative Diseases
Protein Kinases
Genetic Recombination
Brain Stem
Parkinson Disease
Dementia
Chromosomes
Genes
Proteins

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., ... Gasser, T. (2004). Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44(4), 601-607. https://doi.org/10.1016/j.neuron.2004.11.005

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. / Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Müller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas.

In: Neuron, Vol. 44, No. 4, 18.11.2004, p. 601-607.

Research output: Contribution to journalArticle

Zimprich, A, Biskup, S, Leitner, P, Lichtner, P, Farrer, M, Lincoln, S, Kachergus, J, Hulihan, M, Uitti, RJ, Calne, DB, Stoessl, AJ, Pfeiffer, R, Patenge, N, Carbajal, IC, Vieregge, P, Asmus, F, Müller-Myhsok, B, Dickson, DW, Meitinger, T, Strom, TM, Wszolek, ZK & Gasser, T 2004, 'Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology', Neuron, vol. 44, no. 4, pp. 601-607. https://doi.org/10.1016/j.neuron.2004.11.005
Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004 Nov 18;44(4):601-607. https://doi.org/10.1016/j.neuron.2004.11.005
Zimprich, Alexander ; Biskup, Saskia ; Leitner, Petra ; Lichtner, Peter ; Farrer, Matthew ; Lincoln, Sarah ; Kachergus, Jennifer ; Hulihan, Mary ; Uitti, Ryan J. ; Calne, Donald B. ; Stoessl, A. Jon ; Pfeiffer, Ronald ; Patenge, Nadja ; Carbajal, Iria Carballo ; Vieregge, Peter ; Asmus, Friedrich ; Müller-Myhsok, Bertram ; Dickson, Dennis W. ; Meitinger, Thomas ; Strom, Tim M. ; Wszolek, Zbigniew K. ; Gasser, Thomas. / Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. In: Neuron. 2004 ; Vol. 44, No. 4. pp. 601-607.
@article{f71603f6182147369947757055b1dc78,
title = "Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology",
abstract = "We have previously linked families with autosomal-dominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathology, and progressive supranuclear palsy-like pathology. Clinical diagnoses of Parkinsonism with dementia or amyotrophy or both, with their associated pathologies, are also noted. Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism.",
author = "Alexander Zimprich and Saskia Biskup and Petra Leitner and Peter Lichtner and Matthew Farrer and Sarah Lincoln and Jennifer Kachergus and Mary Hulihan and Uitti, {Ryan J.} and Calne, {Donald B.} and Stoessl, {A. Jon} and Ronald Pfeiffer and Nadja Patenge and Carbajal, {Iria Carballo} and Peter Vieregge and Friedrich Asmus and Bertram M{\"u}ller-Myhsok and Dickson, {Dennis W.} and Thomas Meitinger and Strom, {Tim M.} and Wszolek, {Zbigniew K.} and Thomas Gasser",
year = "2004",
month = "11",
day = "18",
doi = "10.1016/j.neuron.2004.11.005",
language = "English (US)",
volume = "44",
pages = "601--607",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

AU - Zimprich, Alexander

AU - Biskup, Saskia

AU - Leitner, Petra

AU - Lichtner, Peter

AU - Farrer, Matthew

AU - Lincoln, Sarah

AU - Kachergus, Jennifer

AU - Hulihan, Mary

AU - Uitti, Ryan J.

AU - Calne, Donald B.

AU - Stoessl, A. Jon

AU - Pfeiffer, Ronald

AU - Patenge, Nadja

AU - Carbajal, Iria Carballo

AU - Vieregge, Peter

AU - Asmus, Friedrich

AU - Müller-Myhsok, Bertram

AU - Dickson, Dennis W.

AU - Meitinger, Thomas

AU - Strom, Tim M.

AU - Wszolek, Zbigniew K.

AU - Gasser, Thomas

PY - 2004/11/18

Y1 - 2004/11/18

N2 - We have previously linked families with autosomal-dominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathology, and progressive supranuclear palsy-like pathology. Clinical diagnoses of Parkinsonism with dementia or amyotrophy or both, with their associated pathologies, are also noted. Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism.

AB - We have previously linked families with autosomal-dominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathology, and progressive supranuclear palsy-like pathology. Clinical diagnoses of Parkinsonism with dementia or amyotrophy or both, with their associated pathologies, are also noted. Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism.

UR - http://www.scopus.com/inward/record.url?scp=8844233579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8844233579&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2004.11.005

DO - 10.1016/j.neuron.2004.11.005

M3 - Article

C2 - 15541309

AN - SCOPUS:8844233579

VL - 44

SP - 601

EP - 607

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 4

ER -